Bausch Health Companies Inc BHC:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
6.88UNCH (UNCH)
Volume
64,324
Close
6.88quote price arrow down-0.07 (-1.01%)
Volume
4,218,050
52 week range
5.57 - 11.46
Loading...
  • Open6.98
  • Day High7.05
  • Day Low6.81
  • Prev Close6.95
  • 52 Week High11.46
  • 52 Week High Date04/03/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23

Key Stats

  • Market Cap2.484B
  • Shares Out360.99M
  • 10 Day Average Volume3.86M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change-14.21

KEY STATS

  • Open6.98
  • Day High7.05
  • Day Low6.81
  • Prev Close6.95
  • 52 Week High11.46
  • 52 Week High Date04/03/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23
  • Market Cap2.484B
  • Shares Out360.99M
  • 10 Day Average Volume3.86M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change-14.21

RATIOS/PROFITABILITY

  • EPS (TTM)-1.24
  • P/E (TTM)-5.53
  • Fwd P/E (NTM)1.83
  • EBITDA (TTM)2.937B
  • ROE (TTM)-441.96%
  • Revenue (TTM)8.966B
  • Gross Margin (TTM)70.81%
  • Net Margin (TTM)-5.34%
  • Debt To Equity (MRQ)-1,979.73%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

April Monthly Meeting: Jim Cramer shares his outlook as earnings season heats up
VIDEO1:06:1001:06:10
April Monthly Meeting: Jim Cramer shares his outlook as earnings season heats up

Profile

MORE
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Controller
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada

Top Peers

SYMBOLLASTCHG%CHG
BHC
Bausch Health Companies Inc
6.88-0.07-1.01%
GUD
CPH
HLS
RX
Biosyent Inc
8.50-0.09-1.05%